Philip Hobson
The Francis Crick Institute(GB)
Publications by Year
Research Areas
Immune cells in cancer, Immunotherapy and Immune Responses, Immune responses and vaccinations, Cancer Immunotherapy and Biomarkers, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Preexisting and de novo humoral immunity to SARS-CoV-2 in humans(2020)983 cited
- → Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination(2021)556 cited
- → AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC(2021)134 cited
- → Bacillus subtilis spores: A novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen(2007)105 cited
- → Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells(2008)105 cited
- → Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer(2024)91 cited
- → Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients(2021)91 cited
- → Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study(2021)89 cited
- → Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans(2020)85 cited
- → Soluble CD23 Controls IgE Synthesis and Homeostasis in Human B Cells(2012)75 cited